Pharma Focus

Providers must be aware of the common and uncommon side effects associated with each agent and class of medication.

Eileen Chang, MD; Soshian Sarrafpour, MD; and Christopher C. Teng, MD

Insights into the use of these treatments as additive therapies for IOP reduction.

Vladislav P. Bekerman, MD, MBA, and Albert S. Khouri, MD